Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06437457
Status:
COMPLETED
Last Update Posted:
2024-05-31
First Post:
2024-05-25
Brief Title:
Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma 5cmA Retrospective Study
Sponsor:
Anhui Medical University
Organization:
Anhui Medical University
Study Overview
Official Title:
Comparison of CE-MRI and CEUS for Measuring Tumor Size of HCC
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Knowing the tumor size before operation is of great significance to the choice of treatment methods of surgeons and the prognosis of patients In this study two commonly used imaging methods CE-MRICEUS were selected to measure and compare the tumor size before operation in order to determine which measurement method is more accurate
Detailed Description:
A total of 194 patients who met the inclusion criteria from January 2019 through May 2024 were included Taken pathological results as the gold standard Paired T-test and Bland-Altman analisis were conducted to assess the correlation and mean absolute error between the measured tumor sizes obtained from CE-MRICEUS and pathological results
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None